Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy

Overview of attention for article published in Cochrane database of systematic reviews, December 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)

Mentioned by

policy: 1 policy source

twitter: 1 tweeter

Citations

dimensions_citation: 159 Dimensions

Readers on

mendeley: 157 Mendeley

Summary Policy documents Twitter Dimensions citations

So far, Dimensions has found 159 publications that cite this research output.

159

The most recent citing publications are shown below. View all 159 publications that cite this research output on Dimensions.

Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathy

Article in BMC Neurology (May 2023)

Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis

Article in Neurology and Therapy (May 2023)

Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of neurologic sequelae in patients with post‐acute sequelae of SARS‐CoV‐2 infection (PASC)

Article in PM&R (May 2023)